Literature DB >> 8245059

Fractures in large-segment allografts.

R C Thompson1, E A Pickvance, D Garry.   

Abstract

Sixteen of thirty-five large-segment allografts that had been implanted after resection for neoplastic conditions, and had been followed for a minimum of thirty-six months, were found to have fractured at a mean of twenty-six months after the implantation. Thirteen of the fractures were treated operatively, and we found a lack of vascularization and soft-tissue attachments to the graft at the fracture site. For seven fractured grafts, there were radiographic and clinical signs of union with the host bone. Eight of the sixteen grafts that had fractured were salvaged with one or more autogenous bone grafts, and two healed spontaneously. Thus, twenty-nine of the thirty-five grafting procedures were considered to have been successful in that the initial objective--provision of a functional segment for skeletal replacement--had been achieved. Multivariate analysis revealed a significant correlation for fracture in patients who were receiving chemotherapy when internal fixation of the graft had included devices that penetrated the cortices of the graft (p < 0.05).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8245059     DOI: 10.2106/00004623-199311000-00011

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  21 in total

1.  Distal femoral osteoarticular allografts: long-term survival, but frequent complications.

Authors:  Patrick C Toy; Jeremy R White; Mark T Scarborough; William F Enneking; C Parker Gibbs
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

2.  Surgical revascularization induces angiogenesis in orthotopic bone allograft.

Authors:  Wouter F Willems; Thomas Kremer; Patricia Friedrich; Allen T Bishop
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

Review 3.  [Extracorporeal irradiation : Reimplantation of bone segments in the treatment of malignant bone tumours].

Authors:  A H Krieg
Journal:  Orthopade       Date:  2017-08       Impact factor: 1.087

4.  The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720.

Authors:  Caren E Petrie Aronin; Soo J Shin; Kimberly B Naden; Peter D Rios; Lauren S Sefcik; Sarah R Zawodny; Namory D Bagayoko; Quanjun Cui; Yusuf Khan; Edward A Botchwey
Journal:  Biomaterials       Date:  2010-09       Impact factor: 12.479

5.  Failure rates and functional results for intercalary femur reconstructions after tumour resection.

Authors:  J I Albergo; L C Gaston; G L Farfalli; M Laitinen; M Parry; M A Ayerza; M Risk; L M Jeys; L A Aponte-Tinao
Journal:  Musculoskelet Surg       Date:  2019-03-08

6.  Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation.

Authors:  Cynthia Huang; Anusuya Das; Daniel Barker; Sunil Tholpady; Tiffany Wang; Quanjun Cui; Roy Ogle; Edward Botchwey
Journal:  Cell Tissue Res       Date:  2011-08-24       Impact factor: 5.249

Review 7.  Massive proximal femoral osteoarticular allograft.

Authors:  P Bohm; E Renner; K Rossak
Journal:  Arch Orthop Trauma Surg       Date:  1996       Impact factor: 3.067

8.  What Is the Outcome of Allograft and Intramedullary Free Fibula (Capanna Technique) in Pediatric and Adolescent Patients With Bone Tumors?

Authors:  Matthew T Houdek; Eric R Wagner; Anthony A Stans; Alexander Y Shin; Allen T Bishop; Franklin H Sim; Steven L Moran
Journal:  Clin Orthop Relat Res       Date:  2016-03       Impact factor: 4.176

9.  Radiographic evaluation of the complications of long bone allografts.

Authors:  H J Griffiths; J R Anderson; R C Thompson; P Amundson; T Detlie
Journal:  Skeletal Radiol       Date:  1995-05       Impact factor: 2.199

Review 10.  Fractures in bone tumour prosthesis.

Authors:  Andrea Piccioli; Barbara Rossi; Federico Maria Sacchetti; Maria Silvia Spinelli; Alberto Di Martino
Journal:  Int Orthop       Date:  2015-08-26       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.